Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti–human immunodeficiency virus potency and breadth with minimal immunogenicity-Reference-Cited by-同舟云学术

Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti–human immunodeficiency virus potency and breadth with minimal immunogenicity

Published:2018-03 Issue:3 Volume:20 Page:407-419
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Ghanem Mustafa H.,Bolivar-Wagers Sara,Dey Barna,Hajduczki Agnes,Vargas-Inchaustegui Diego A.,Danielson David T.,Bundoc Virgilio,Liu Li,Berger Edward A.

Funder

Division of Intramural Research of National Institute of Allergy and Infectious Diseases

National Institutes of Health Intramural AIDS Targeted Antiviral Program

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference65 articles.

1. The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities;Doherty;Curr Opin HIV AIDS,2013

2. HIV cure research: a formidable challenge;Ananworanich;J Virus Eradiation,2015

3. Progress toward HIV eradication: case reports, current efforts, and the challenges associated with cure;Martin,2016

4. International AIDS Society global scientific strategy: towards an HIV cure;Deeks;Nat Med,2016

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseases;Med;2024-06

2. Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study;Cell Discovery;2024-05-14

3. Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission;Current Opinion in HIV and AIDS;2024-05-01

4. New Era of CAR T Cells for Infectious Viral Diseases;Emerging Human Viral Diseases, Volume II;2024

5. Strategies for HIV-1 elimination;HIV-Associated Neurocognitive Disorders;2024